Tags:CenterMedTechPlatformProductResearch
Nohla Therapeutics is a cellular therapy company driven to provide leading off the shelf therapies for patients with critical diseases. Nohla’s first product is a universal donor cell therapy targeting hematopoietic recovery and chemotherapy induced neutropenia, and is being extended to treat a range of other medical indications. This and other products in the pipeline are based on a unique umbilical cord blood expansion platform developed at the Fred Hutchinson Cancer Research Center
Location: United States, Washington, Seattle
Member count: 51-200
Total raised: $120.5M
Founded date: 2015

Investors 1

DateNameWebsite
17.07.2021ARCH Ventu...archventur...

Funding Rounds 4

DateSeriesAmountInvestorsDeal News
12.07.2018Series B$11M-finsmes.co...
16.05.2018Series B$45M5AM Ventur...geekwire.c...
29.11.2016Series A$43.5MARCH Ventu...citybizlis...
28.12.2015-$21M-finsmes.co...

Mentions in press and media 14

DateTitleDescriptionCategoryAuthorSource
12.07.2018Nohla Ther...Nohla Therapeutics founder and...-Taylor Sop...geekwire.c...
12.07.2018Nohla Ther...Nohla Therapeutics, a Seattle,...USA-finsmes.co...
16.05.2018Nohla Ther...Nohla Therapeutics, a Seattle,...USA-finsmes.co...
15.05.2018Nohla Ther...Nohla Therapeutics Founder and...-Clare McGr...geekwire.c...
05.04.2017GeekWire A...Arivale CEO Clayton Lewis and ...-John Cookgeekwire.c...
09.02.2017Inside Noh...Left to right: Governor Jay In...-Clare McGr...geekwire.c...
30.11.2016Nohla Ther...Nohla Therapeutics Inc., a Sea...USA-finsmes.co...
30.11.20165AM Ventur...SEATTLE, Nov. 29, 2016 (GLOBE ...--citybizlis...
30.11.2016Term Sheet...ET CETERA • Startups in India...--fortune.co...
30.11.2016ARCH Ventu...SEATTLE, Nov. 29, 2016 (GLOBE ...--citybizlis...
Show more